The CRISPR revolution arrives in immuno-oncology
Posted in Exclusive Content
| Tagged AI / data analytics / healthtech / informatics, Analysis, Assay development optimisation & technology, Biomarkers, Business, Cell culture, Cell therapy, Cellular & Molecular biology, Cellular assays, Chemistry, Drug development, Drug discovery, Drug targets, Enabling technologies, Gene editing, Gene therapy, Genetics / genomes, High Content Screening, High throughput screening, In Silico Biology, Lead discovery, Molecular medicine, Oncology, Precision medicine, Protein chemistry / Proteomics, RNA, Screening, Stem cells, System biology, Systems biology, Target validation, Therapeutics, Translational, Translational chemistry
